Vaccine programmes and policies

British Medical Bulletin

Volumn 62, Issue , 2002, Pages 201-211

  Salisbury, D M ^a   Beverley, P C L ^b,c   Miller, E ^b,c  

^a Department of Health ^*  (United Kingdom)

^b EDWARD JENNER INST FOR VACC RES   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACELLULAR VACCINE; BCG VACCINE; CHICKENPOX VACCINE; DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; LYME DISEASE VACCINE; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE; PERTUSSIS VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; VACCINE;

CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; HEALTH CARE DELIVERY; HUMAN; INFECTION; MATHEMATICAL MODEL; POLICY; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; TREATMENT PLANNING; VACCINATION;

GREAT BRITAIN; HEALTH PLANNING; HEALTH POLICY; HUMANS; IMMUNIZATION PROGRAMS; MODELS, IMMUNOLOGICAL; VACCINES;

EID: 0036329168     PISSN: 00071420     EISSN: None     Source Type: Journal    
DOI: 10.1093/bmb/62.1.201     Document Type: Review

References (21)

1. Parental refusal to have children immunised: Extent and reasons
2. Vaccine coverage: Recent trends and future prospects
3. COVER programme: July to September 2001
4. Surveillance of antibody to measles, mumps and rubella by age
5. Interpreting serological surveillance data for measles using mathematical models: Implications for vaccine strategy
6. Effect of age on outcome and epidemiology of infectious diseases
7. Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: A success story
8. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children: An early report
9. Evaluating the cost-effectiveness of vaccination programmes: A dynamic perspective
10. Universal or selective vaccination against hepatitis B virus in the United Kingdom? A review of recent cost-effectiveness studies
11. Impact of anti-vaccine movements on pertussis control: The untold story
12. The reporting sensitivities of two passive surveillance systems for vaccine adverse events
13. Risk of aseptic meningitis after measles, mumps and rubella vaccine in UK children
14. A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubelia vaccines
15. Idiopathic thrombocytopenic purpura and MMR vaccine [short report]
16. Autism and measles, mumps, and rubella vaccine: No epidemiological evidence for a causal association